ArticleAnnals of Indian Academy of Neurology2024
COVID-19 Infection in Multiple Sclerosis Patients Treated with Rituximab Compared to Natalizumab and Healthy Controls: A Real-World Multicenter Study.
Thomas Mathew et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.